Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00019669
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02303951
What this trial is testing

Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 47
Testing effectiveness (Phase 2)Study completedNCT00014625
What this trial is testing

E7070 in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 28
Early research (Phase 1)WithdrawnNCT01843738
What this trial is testing

Radiation Use During Vemurafenib Treatment

Who this might be right for
BRAFV600 MutationStage IV Melanoma
University of Utah
Testing effectiveness (Phase 2)Study completedNCT00135408
What this trial is testing

MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 115
Early research (Phase 1)Study completedNCT00636558
What this trial is testing

Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)

Who this might be right for
MelanomaBreast CancerProstate Cancer
Viralytics 8
Large-scale testing (Phase 3)Study completedNCT02388906
What this trial is testing

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 906
Not applicableEnrolling By InvitationNCT06605833
What this trial is testing

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Who this might be right for
Melanoma Stage III or IV
Royal Marsden NHS Foundation Trust 60
Not applicableLooking for participantsNCT06784778
What this trial is testing

Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

Who this might be right for
Melanoma MetastaticMelanoma, SkinMelanoma Stage III or IV+1 more
Pamgene International B.V. 196
Early research (Phase 1)Study completedNCT00030615
What this trial is testing

Decitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Bladder CancerRecurrent Breast Cancer+6 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT06984328
What this trial is testing

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

Who this might be right for
Cutaneous MelanomaRelapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)Metastatic Cutaneous Melanoma (Stage IV)
Genmab 1
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01644591
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 49
Not applicableLooking for participantsNCT07050940
What this trial is testing

Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study

Who this might be right for
Melanoma Metastatic
Azienda Ospedaliera di Perugia 35
Early research (Phase 1)Study completedNCT00003665
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00261365
What this trial is testing

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Who this might be right for
Unresectable Stage III or IV Malignant Melanoma
Bristol-Myers Squibb 80
Testing effectiveness (Phase 2)Study completedNCT01143402
What this trial is testing

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaOcular Melanoma With Extraocular Extension+3 more
National Cancer Institute (NCI) 120
Very early researchStudy completedNCT02320305
What this trial is testing

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Stage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more
Mayo Clinic 23
Testing effectiveness (Phase 2)UnknownNCT00086866
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 165
Testing effectiveness (Phase 2)Ended earlyNCT02414750
What this trial is testing

Vemurafenib Plus Cobimetinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Netherlands Working Group on Immunotherapy of Oncology 78
Next Page